Scientific
MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis
These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.
MK5 Proteome Analysis - Divided Values

Type II network, divided values. Interestingly most of the proteins in the first 100 positions in this table would occur in the divided ranks table between position 100 and 200, indicating a difference in emphasis between the two simulations but not in the overall function. The fully annotated table, include Ensembl gene identifiers and network values can be found in the supplementary data.
Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Value Type description Rank Gene Interaction Map Network Comparison Type Filtered green red network_comparison
Results: HTML CSV LaTeX
Showing element 2030 to 2079 of 3228 in total
Value Type: Measured
Interaction Map: High confidence
Network Comparison Type: Divided
Filtered: 1

\def\wcA{0.16666666666667\textwidth}
\def\wcB{0.16666666666667\textwidth}
\def\wcC{0.16666666666667\textwidth}
\def\wcD{0.16666666666667\textwidth}
\def\wcE{0.16666666666667\textwidth}
\begin{longtable}{|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
phosphoserine aminotransferase (ec 2.6.1.52) (psat). [source:swissprot;acc:q9y617]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1107\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5986.63\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5489.99\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.09046\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
pinch protein (particularly interesting new cys-his protein) (lim and senescent cell antigen-like domains 1). [source:swissprot;acc:p48059]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1868\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6463.12\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6076.66\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.0636\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
pinin, desmosome associated protein; pinin. [source:refseq;acc:nm\_002687]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1227\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6483.32\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5973.95\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.08527\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
placenta growth factor precursor (plgf). [source:swissprot;acc:p49763]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3036\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
placental protein 11 precursor (ec 3.4.21.-) (pp11). [source:swissprot;acc:p21128]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3076\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
placental thrombin inhibitor (cytoplasmic antiproteinase) (cap) (protease inhibitor 6) (pi-6). [source:swissprot;acc:p35237]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2409\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5275.76\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5078.5\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.03884\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
plasma carboxypeptidase b2 isoform a preproprotein; carboxypeptidase u; thrombin-activatable fibrinolysis inhibitor; carboxypeptidase b-like protein; thrombin-activable fibrinolysis inhibitor. [source:refseq;acc:nm\_001872]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
241\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6265.76\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7711.31\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.23071\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
plasminogen activator inhibitor-2 precursor (pai-2) (placental plasminogen activator inhibitor) (monocyte arg-serpin) (urokinase inhibitor). [source:swissprot;acc:p05120]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2407\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5275.76\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5078.5\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.03884\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
platelet-activating factor acetylhydrolase ib alpha subunit (ec 3.1.1.47) (paf acetylhydrolase 45 kda subunit) (paf-ah 45 kda subunit) (paf-ah alpha) (pafah alpha) (lissencephaly-1 protein) (lis- 1). [source:swissprot;acc:p43034]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3221\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
pleckstrin homology domain containing, family c (with ferm domain) member 1; mitogen inducible 2; kindlin 2. [source:refseq;acc:nm\_006832]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1878\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6463.12\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6076.66\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.0636\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
pleiotropic regulator 1 (prl1homolog, arabidopsis); pleiotropic regulator 1 (prl1, arabidopsis homolog). [source:refseq;acc:nm\_002669]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
332\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5975.51\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5051.16\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.183\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
pms1 protein homolog 2 (dna mismatch repair protein pms2). [source:swissprot;acc:p54278]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
762\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6933.9\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6231.31\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.11275\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
pnas-18. [source:sptrembl;acc:q9bzu3]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
306\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
11409.6\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
13680.5\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.19903\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
pogo transposable element with znf domain isoform 1. [source:refseq;acc:nm\_015100]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2932\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
poly (adp-ribose) glycohydrolase. [source:refseq;acc:nm\_003631]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
840\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6395.78\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5786.67\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.10526\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
poly(a) polymerase alpha (ec 2.7.7.19) (pap) (polynucleotide adenylyltransferase alpha) (fragment). [source:swissprot;acc:p51003]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
285\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
19296.4\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
23326.5\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.20885\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
poly(a) polymerase gamma (ec 2.7.7.19) (pap gamma) (polynucleotide adenylyltransferase gamma) (srp rna 3' adenylating enzyme). [source:swissprot;acc:q9bwt3]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
287\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
19279.5\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
23303.1\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.2087\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
polyadenylate-binding protein 1 (poly(a)-binding protein 1) (pabp 1). [source:swissprot;acc:p11940]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1095\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
6316.61\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
5791.05\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.09075\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
polyadenylate-binding protein 3 (poly(a)-binding protein 3) (pabp 3) (testis-specific poly(a)-binding protein). [source:swissprot;acc:q9h361]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1091\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
polyadenylate-binding protein 4 (poly(a)-binding protein 4) (pabp 4) (inducible poly(a)-binding protein) (ipabp) (activated-platelet protein-1) (app-1). [source:swissprot;acc:q13310]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1094\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
polyamine oxidase isoform 1; polyamine oxidase; flavin-containing spermine oxidase; putative cyclin g1 interacting protein; flavin containing amine oxidase. [source:refseq;acc:nm\_019025]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
643\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5414.23\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4810.85\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.12542\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
polybromo 1. [source:refseq;acc:nm\_018165]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2052\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5952.7\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5634.8\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.05642\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
polyglutamine binding protein 1; nuclear protein containing ww domain 38 kd. [source:refseq;acc:nm\_005710]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2579\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5071.53\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4979.44\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.01849\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
polyhomeotic like 3; early development regulator 3; polyhomeotic 3. [source:refseq;acc:nm\_024947]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2809\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
polymerase (dna directed) iota; rad30 (s. cerevisiae) homolog b; polymerase (dna-directed), iota. [source:refseq;acc:nm\_007195]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
283\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6314.35\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5221.28\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.20935\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
polymerase (dna directed) sigma; topoisomerase-related function protein 4-1; polymerase (dna-directed) sigma. [source:refseq;acc:nm\_006999]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
765\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5258.95\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4726.38\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.11268\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
polymerase (rna) iii (dna directed) (32kd). [source:refseq;acc:nm\_006467]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2583\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
3857.88\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3926.4\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.01776\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
polymerase (rna) iii (dna directed) (62kd). [source:refseq;acc:nm\_006468]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2630\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
3928.38\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3985.17\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.01446\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
polymerase delta-interacting protein 1; tnfaip1-like. [source:refseq;acc:nm\_178863]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1156\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6355.89\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5840.77\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.08819\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
polymyositis/scleroderma autoantigen 2 (autoantigen pm/scl 2) (polymyositis/scleroderma autoantigen 100 kda) (pm/scl-100) (p100 polymyositis-scleroderma overlap syndrome associated autoantigen). [source:swissprot;acc:q01780]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2531\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6291.08\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6141.97\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.02428\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
polypeptide n-acetylgalactosaminyltransferase 2; udp-galnac transferase 2. [source:refseq;acc:nm\_004481]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2097\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6356.56\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6024.47\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.05512\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
polyposis locus protein 1 (tb2 protein). [source:swissprot;acc:q00765]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2611\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
6476.18\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6380.6\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.01498\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
polyposis locus protein 1-like 1; likely ortholog of mouse polyposis locus protein 1-like 1. [source:refseq;acc:nm\_138393]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2613\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
polypyrimidine tract binding protein 2; neural polypyrimidine tract binding protein; ptb-like protein. [source:refseq;acc:nm\_021190]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2281\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6048.91\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5783.73\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.04585\vspace{3pt}}}\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
polypyrimidine tract-binding protein 1 (ptb) (heterogeneous nuclear ribonucleoprotein i) (hnrnp i) (57 kda rna-binding protein pptb-1). [source:swissprot;acc:p26599]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2293\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6048.94\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5783.76\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
ponsin; sh3-domain protein 5 (ponsin). [source:refseq;acc:nm\_015385]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
448\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
7190.91\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6259.3\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.14884\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
porphobilinogen deaminase (ec 4.3.1.8) (hydroxymethylbilane synthase) (hmbs) (pre-uroporphyrinogen synthase) (pbg-d). [source:swissprot;acc:p08397]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1202\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5337.95\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4913.07\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.08648\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
possible global transcription activator snf2l1. [source:swissprot;acc:p28370]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2055\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
5952.7\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
5634.8\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.05642\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
possible global transcription activator snf2l2 (snf2-alpha). [source:swissprot;acc:p51531]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2057\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
possible global transcription activator snf2l4 (snf2-beta) (brg-1 protein) (mitotic growth and transcription activator) (brahma protein homolog 1). [source:swissprot;acc:p51532]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2054\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
postsynaptic protein cript; hspc139 protein. [source:refseq;acc:nm\_014171]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3034\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
potassium channel modulatory factor 1; potassium channel modulatory factor; differentially expressed in branching tubulogenesis 91; zinc finger, zz domain containing 1. [source:refseq;acc:nm\_020122]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1816\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5997\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5633.44\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06454\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
potassium channel tetramerisation domain containing 3; ny-ren-45 antigen. [source:refseq;acc:nm\_016121]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2975\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
potassium channel-interacting protein 4 isoform 4; calsenilin-like protein. [source:refseq;acc:nm\_147183]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
139\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
2099.49\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
2759.61\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.31442\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
potassium voltage-gated channel subfamily a member 1 (potassium channel kv1.1) (huki) (hbk1). [source:swissprot;acc:q09470]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2188\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
7018.29\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6682.7\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.05022\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
potassium voltage-gated channel subfamily a member 2 (potassium channel kv1.2) (rbk2) (hbk5) (ngk1) (mk2) (hukiv). [source:swissprot;acc:p16389]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2176\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
7015.93\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6674.58\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.05114\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
potassium voltage-gated channel subfamily a member 4 (potassium channel kv1.4) (hk1) (hpcn2) (hbk4) (hukii). [source:swissprot;acc:p22459]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2196\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
7020.02\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6688.64\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.04954\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
potassium voltage-gated channel, shal-related subfamily, member 1; shal-type potassium channel; voltage-gated potassium channel kv4.1. [source:refseq;acc:nm\_004979]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
91\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1700.8\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
2416.53\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.42082\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
potassium voltage-gated channel, shal-related subfamily, member 2; voltage-sensitive potassium channel; voltage-gated potassium channel kv4.2. [source:refseq;acc:nm\_012281]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
88\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1695.45\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
2411.93\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.42259\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
potassium voltage-gated channel, shal-related subfamily, member 3 isoform 1; sha1-related potassium channel kv4.3; voltage-gated k+ channel; potassium ionic channel kv4.3; voltage-gated potassium channel kv4.3. [source:refseq;acc:nm\_004980]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
90\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1698.75\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
2414.77\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.4215\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/